ProTreat: An Adaptive and Rapid Implementation Trial of Novel Therapies to Prevent and Treat COVID19 Infection in High Risk Cancer Patients

Grant number: 2002213 | Funding period: 2020 - 2022

Completed

University of Melbourne Researchers